ToxStrategies scientists have published a manuscript in the journal Regulatory Toxicology and Pharmacology reporting the outcome of a state-of-the-science assessment to develop recommendations… read more
We are thrilled to announce that Dr. Fernando Sampedro has joined ToxStrategies LLC, bringing his broad expertise and depth of experience to our Foods… read more
EpidStrategies, a Division of ToxStrategies LLC, is pleased to announce the addition of Dr. Michael Kelsh to our team, adding considerable depth to… read more
ToxStrategies scientists Marcie Wood, Ph.D. and Kirsten Mease, B.S. will be presenting at The Charles River Biotech Symposium – Biotechnology-Derived Therapeutics Perspectives on… read more
For more than a century, radiation health has been a concern for the public and for workers. However, the launch of the Hollywood… read more
In the United States, a new monoclonal antibody (nirsevimab; trade name: Beyfortus) was recently approved by the FDA and recommended by the CDC… read more
Coal Combustion Residuals (CCRs) are generated from the combustion of coal in producing steam for generation of electricity by electric utilities and independent… read more
ToxStrategies LLC is excited to announce that Modality Solutions is joining forces with our firm, greatly expanding our ability to serve the evolving needs of… read more
